The European venture firm raised 500 million euros, or about $579 million, for its latest fund, which follows a flurry of recent buyout deals involving portfolio companies like Merus and Vicebio.Medicxi, a European life sciences venture capital firm, said Friday it raised 500 million euros, or about $579 million, for its sixth investment fund.The firm […]
